Illumina

Illumina is a US-headquartered life science company and the dominant provider of next-generation sequencing platforms and array-based genotyping tools.

Its UK operations are based at Granta Park in Cambridge, serving as its primary European research and commercial hub.

Illumina's technologies underpin applications in oncology, reproductive health, clinical diagnostics and population genomics. Its sequencing-by-synthesis chemistry, originating from Cambridge-based Solexa, accounts for the majority of global sequencing data generated today.